The biotech says that its AKT1 blockers can overcome toxicity challenges associated with PI3K/AKT inhibitors through ...

Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time ...

When a child’s symptoms stump one specialist after another for years on end, families describe the experience as grueling and ...

Company entered into an asset purchase agreement with Johnson & Johnson (J&J) to acquire all interests in botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis pigmentosa (XLRP ...

In the May + June 2026 issue, we investigate our new AI overlords and the world they are striving to create, whether we like ...

Dhaka, April 16 -- A genetic adaptation that helps animals like yaks and Tibetan antelopes survive in low-oxygen environments could open up a new pathway for repairing nerve damage in humans, ...

A surprising discovery from high-altitude animals like yaks and Tibetan antelopes could reshape how we treat nerve damage in humans. Scientists found that a genetic mutation helping these animals ...

A team of scientists from NTU Singapore has developed a new biochip that, when paired with artificial intelligence, can ...

Mayo Clinic's Translational Neuromuscular Disease Research Lab led by Nathan P. Staff, M.D., Ph.D., studies the biological ...

A comprehensive approach is necessary for navigating the highly heterogeneous nature of leukemia across different age ...

Scientists are rethinking how to treat a widespread genetic cholesterol disorder by targeting particle production instead of removal.

With a new $6.2 million, five-year grant from the National Institute on Aging, researchers at Case Western Reserve University will use artificial intelligence (AI) and machine learning to identify ...